Study of a new drug for inflammation and healthy volunteers
This study tests a new drug called LY5625575 in healthy people and in people with inflammation (measured by a blood test called C-reactive protein). The goal is to see if the drug is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult or have mild inflammation (based on a blood test).
- You cannot be able to have children (or must be male at birth).
- You must not have any significant medical problems or recent surgeries.
- You must meet specific kidney, body mass index (BMI), or ancestry criteria depending on the part of the study.
- You must not have certain infections, allergies, or recent vaccinations or medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new medicine called LY5625573 in healthy volunteers and people with mild inflammation (measured by a blood test called C-reactive protein). It helps researchers understand how the medicine works in the body and if it is safe.
This is a Phase 1 study testing a new medicine called LY4178256. It will check how the drug is processed by the body and its safety in healthy volunteers. The results help doctors understand how to dose the drug in future studies.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Hear when a new C-Reactive Protein trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.